OSAKA -- A Japanese research team is developing an immunotherapy to treat COVID-19 using embryonic stem cells.
Immunotherapy creates killer T cells that detect coronavirus markers

Researchers from Japan's Kyoto University discovered a technique to produce white blood cells that attack COVID-infected cells. (Photo by Yo Inoue)
OSAKA -- A Japanese research team is developing an immunotherapy to treat COVID-19 using embryonic stem cells.